Birdwatch Note
2023-04-16 23:14:36 UTC - NOT_MISLEADING
This subject is still being debated. Medical professionals dispute one another and case reports, controlled trials, & diagram illustrations are often contradictory. Any challenges or supplemental information should be made in replies to the tweet author. No note is needed.
Written by A8F0DE6D6FCF5540C9EBBE6B476B41D75CFB863585D0BEFBF26C51C91BC5F06B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1647658944469319681
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1647740303946784770
- noteId - 1647740303946784770
- participantId -
- noteAuthorParticipantId - A8F0DE6D6FCF5540C9EBBE6B476B41D75CFB863585D0BEFBF26C51C91BC5F06B Participant Details
- createdAtMillis - 1681686876654
- tweetId - 1647658944469319681
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 0
- summary
- This subject is still being debated. Medical professionals dispute one another and case reports, controlled trials, & diagram illustrations are often contradictory. Any challenges or supplemental information should be made in replies to the tweet author. No note is needed.
Note Ratings
| rated at | rated by | |
| 2023-05-09 13:16:58 -0500 | Rating Details | |
| 2023-04-16 18:28:43 -0500 | Rating Details | |
| 2023-04-16 19:14:50 -0500 | Rating Details | |
| 2023-04-16 19:37:49 -0500 | Rating Details | |
| 2023-04-16 22:43:02 -0500 | Rating Details | |
| 2023-04-16 18:22:00 -0500 | Rating Details | |
| 2023-04-16 20:17:34 -0500 | Rating Details | |
| 2023-04-16 19:41:00 -0500 | Rating Details | |
| 2023-04-16 18:37:03 -0500 | Rating Details | |
| 2023-04-16 19:25:18 -0500 | Rating Details | |
| 2023-04-17 00:39:24 -0500 | Rating Details | |
| 2023-04-17 08:32:10 -0500 | Rating Details | |
| 2023-04-16 18:28:43 -0500 | Rating Details | |
| 2023-04-16 19:14:50 -0500 | Rating Details | |
| 2023-04-16 19:37:49 -0500 | Rating Details | |
| 2023-04-16 22:43:02 -0500 | Rating Details | |
| 2023-04-16 18:22:00 -0500 | Rating Details | |
| 2023-04-16 20:17:34 -0500 | Rating Details | |
| 2023-04-16 19:41:00 -0500 | Rating Details | |
| 2023-04-16 18:37:03 -0500 | Rating Details | |
| 2023-05-09 13:16:58 -0500 | Rating Details | |
| 2023-04-16 19:25:18 -0500 | Rating Details | |
| 2023-04-17 00:39:24 -0500 | Rating Details | |
| 2023-04-17 08:32:10 -0500 | Rating Details |